Study of icosapent ethyl for high-risk heart plaque
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a medication called icosapent ethyl (a type of fish oil) to see if it can reduce inflammation in dangerous heart plaques. It might help prevent heart attacks or strokes in people with certain high-risk plaque features.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are already taking a stable dose of a cholesterol-lowering statin for at least 4 weeks.
- Your fasting triglyceride level is below 5.6 mmol/L.
- A recent heart CT scan (CCTA) shows at least one high-risk plaque feature.
- You have not had a heart attack, stroke, or heart procedure in the last 3 months.
- You are not currently taking certain medications that affect inflammation (like corticosteroids or immunosuppressants).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called icosapent ethyl (a purified fish oil) can help reduce plaque buildup in heart arteries and lower inflammation in people with heart disease. Researchers will use imaging and blood tests to see if it protects your heart.
This study compares two ways to lower cholesterol and stabilize artery plaque in people with coronary artery disease who are having a stent procedure. It tests whether a moderate statin plus ezetimibe works as well as a high-intensity statin alone for stabilizing plaque.
This trial tests whether a powerful cholesterol-lowering drug (PCSK9 inhibitor) helps stabilize plaque in heart arteries after a recent heart attack or unstable angina treated with a stent. It may lower the risk of future heart problems.
This study tests whether adding a PCSK9 inhibitor (a newer cholesterol-lowering shot) to standard treatment can reduce heart risks in people who have certain high-risk plaque features seen on a CT scan of their heart arteries.
This study tests whether a medication called a PCSK9 inhibitor (a type of drug that lowers bad cholesterol) can improve the buildup of plaque in heart arteries. It may be an option for people with coronary artery disease who have not been helped enough by statins alone.
This trial tests whether a single injection of a PCSK9 inhibitor (a cholesterol-lowering medicine) can improve heart health after a stent procedure. It is for people who have a certain amount of fat buildup in their treated artery.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.